Ponni Sugars (Erode) Limited

Consumer Defensive — Confectioners · NSE

₹374.50+₹3.70 (+1.00%)

DalalBaazaar Score

61 / 100

🟢 Good

Verdict

NEUTRAL

Risk

Moderate

Driven by micro-cap size, which brings thin liquidity.

In simple words: Reasonable but unspectacular business quality, with both sales and profits growing well. Nothing obvious stands out as stretched — the usual checks on business quality and management still apply.

Decision support, not a buy or sell call.

As of 18 Oct 2026, 7:03 pm

Understanding the Business

Company site ↗

The 60-second version of Ponni Sugars (Erode) Limited — what it does, how it earns, and who it competes with, before any of the numbers below.

What does this company do?

Ponni Sugars (Erode) Limited manufactures and sells sugar in India. It operates through Sugar and Cogeneration segments. The company is involved in the provision of bagasse and molasses; and cogeneration of power. It also exports its products.

IndustryConfectioners

SectorConsumer Defensive

Employees174

Annual revenue₹415 Cr

How does it make money?

Turns over ₹415 Cr a year. Of every ₹100 of sales, about ₹12 reaches shareholders as profit, with ₹13 left at the operating level before interest, tax and depreciation. Each of its 174 employees supports ₹2.38 Cr of revenue a year, the signature of a capital- or asset-led business.

Revenue / employee₹2.38 Cr

Who are its competitors?

The closest listed comparisons in its industry are HINDUSTAN UNILEVER LTD., ITC LTD, NESTLE INDIA LIMITED, BRITANNIA INDUSTRIES LTD. These are the companies its valuation and returns are measured against elsewhere in this report.

Compared side by side in Peers ↓

What is its competitive advantage?Little sign of one

Returns on capital of 14.8% are at or below what the capital likely costs. That is the financial pattern of a business competing largely on price, where advantage has to come from execution rather than position.

Peer median ROE51.0%

What has been driving growth?

Profit has moved mainly because margins changed, not because the business sold much more. Over 3 years revenue moved -5% while net margin moved +31% relative to itself. What this cannot tell you is which products, customers or geographies did the work — that lives in the segment disclosures of the annual report.

Revenue effect-5%

Margin effect+31%

DalalBaazaar Score

61/ 100

Good

Weighted across six categories. Every point is explained below.

✗ Revenue has contracted at 1.6% a year
✗ Profit CAGR of only 7.8%

Quality vs. Valuation

Company Quality

58/ 100

Average

How good the business is, ignoring the share price entirely.

Valuation

88/ 100

Cheap

What you are being asked to pay, ignoring how good the business is.

A reasonable business at a reasonable price — neither the quality nor the valuation stands out in either direction.

Historical Valuation

Current P/E

6.5x

3Y Median

9.4x

40 monthly readings · mean 9.5x · range 5.4x–13.8x

Sector Median

43.3x

median of 4 sector peers

🟢Current valuation is approximately 31% below its 3y median of 9.4x. Cheaper than its own history, which is worth a reason too: the market may be pricing in something the backward-looking numbers do not show.

🟢Against its sector it trades 85% below the peer median of 43.3x.

vs. its own history

Cheap

9.4x median over 40 months · -31%

vs. sector peers

Cheap

43.3x median of 4 peers · -85%

vs. generic bands

Cheap

Below 15x

EV/EBITDA

6.2x

PEG

0.83

What's Good / What's Bad

🟢 What's Going Well3

Cash generation is improving
Free cash flow is up 11438% over 3 years.
Return on capital is rising
ROCE has improved from 10.2% to 14.8%.
Consistently profitable
Profitable in every one of the last 4 reported years.

🔴 What Needs Attention0

Nothing stands out as clearly deteriorating on the years of data available.

Red Flags

1 item require attention · 1 high

🔴Inventory building faster than salesFinancial
Inventory up 55% against revenue up -5% — stock may not be moving.

Investment Thesis

🟢 Bull CaseWhat could make this work?

Priced below its own history
The stock trades 31% below its own median multiple. If the business performs as it has and simply re-rates back to normal, that gap is return on its own.
Cheaper than its peers
It trades 85% below the sector median. Either the market sees a problem the numbers do not show, or the discount closes.
Earnings have proved durable
Profitable in every one of the last 4 reported years. Consistency lowers the risk that any single bad year is structural rather than cyclical.

🔴 Bear CaseWhat could go wrong?

Earnings are hard to forecast
Profit has swung sharply from year to year, so any single year — good or bad — is a weak guide to the next. Cyclical earnings deserve lower multiples for that reason.
Size brings its own risk
Micro Cap businesses are thinly traded, so exits are harder in a falling market and single events move the price more than they would for a larger company.

🟡 Key Things to WatchMeasurable tripwires, set against where this company stands today

1EBITDA margin holds above 11%✓ 12.5%
Two points below today's level — enough room for noise, tight enough to catch real compression.
2Free cash flow remains positive✓ ₹15 Cr
Profit that never becomes cash eventually stops being profit.
3ROCE stays above 12%✓ 14.8%
Falling returns on capital are usually competition arriving, and show up here before they reach the margin.
4Valuation vs its own median of 9.4x✓ 6.5x today
A re-rating above its own history needs a reason; without one it is just a higher price.

Investment Checklist

7 / 10 checks passed

✗ Strong return on equity (ROE ≥ 15%)
✗ Strong return on capital employed (ROCE ≥ 15%)
✓ Healthy net margin (≥ 10%)
✓ Generates positive free cash flow
✓ Adequate short-term liquidity (Current Ratio ≥ 1.0)
✓ Revenue growing year-over-year
✓ Profit growing year-over-year
✓ Not trading at an extreme valuation (P/E < 40x)
✓ Not buying right at the 52-week high
✗ Short-term technical trend isn't bearish

Price history

Quick Metrics

6 good · 5 neutral · 0 weak

Market Cap

₹322 Cr

Micro Cap

Smaller company — thin liquidity and deep drawdowns are normal here

P/E (Trailing)

6.5x

Cheap

Cheap against the generic band

P/B Ratio

0.57x

Reasonable

Reasonable against the company's book value

EPS (TTM)

₹57.53

Profitable

Profitable on a per-share basis

ROE

8.5%

Moderate

Moderate capital efficiency

ROCE

14.8%

Moderate

Moderate return on the capital in the business

Debt/Equity

Not available

No data

Source didn't return this field

Revenue Growth (YoY)

52.2%

Healthy

Healthy top-line growth

Profit Growth (YoY)

149.1%

Healthy

Profits growing at a healthy clip

Dividend Yield

1.34%

Modest

Small cash return — most of the return has to come from the price

Free Cash Flow

₹15 Cr

Cash generative

Generates cash even after funding its capex

More Metrics

Operating Margin

-5.1%

Weak

Thin margins leave little room for error

Net Margin

11.1%

Good

Strong bottom-line conversion

Current Ratio

5.66

Comfortable

Healthy short-term liquidity

Beta (vs Nifty)

0.10

Defensive

Steadier than the market

52W Range Position

60%

Mid-range

Technical Snapshot

SMA 20 / SMA 50

369.4 / 370.7

Bearish alignment (short < long)

Price vs SMA 200

Above

Long-term uptrend

RSI (14)

37.6

Neutral momentum

Financial Trend (4-Year)

Metric	FY23	FY24	FY25	FY26	3Y CAGR
Revenue	₹435 Cr	₹421 Cr	₹359 Cr	₹415 Cr	-1.6%
EBITDA	₹60 Cr	₹61 Cr	₹38 Cr	₹52 Cr	-4.7%
EBITDA Margin	13.8%	14.4%	10.6%	12.5%	—
PAT (Net Profit)	₹38 Cr	₹47 Cr	₹19 Cr	₹48 Cr	+7.8%
EPS	₹44.58	₹54.49	₹22.42	₹55.85	+7.8%
ROE	8.5%	8.5%	3.6%	8.5%	—
ROCE	10.2%	9.1%	5.1%	14.8%	—
Free Cash Flow	₹0 Cr	₹1 Cr	-₹17 Cr	₹15 Cr	+386.8%

🟡 Revenue has been broadly flat over 3 years (-1.6% a year).

🔴 EBITDA has shrunk at 4.7% a year over 3 years.

🔴 EBITDA Margin has fallen from 13.8% to 12.5% over 3 years (-1.3 pts).

🟢 PAT (Net Profit) has grown at 7.8% a year over 3 years.

🟢 EPS has grown at 7.8% a year over 3 years.

🟡 ROE has held roughly flat at 8.5% over 3 years.

🟢 ROCE has risen from 10.2% to 14.8% over 3 years (+4.5 pts).

🟢 Free Cash Flow has grown at 386.8% a year over 3 years.

Balance Sheet & Cash Flow — FY2026

Total Assets

₹652 Cr

Total Liabilities

₹84 Cr

Total Debt

—

Cash & Equivalents

₹2 Cr

Operating Cash Flow

₹31 Cr

Capex

-₹16 Cr

Shareholding (proxy)

Institutional Holding

5.8%

Insider Holding

52.7%

Corporate Actions

Dividend Rate

₹5

Ex-Dividend Date

05 Jun 2026

Peer Comparison

Company	P/E	ROE
HINDUSTAN UNILEVER LTD.	42.5x	21.5%
ITC LTD	16.6x	27.4%
NESTLE INDIA LIMITED	59.8x	79.9%
BRITANNIA INDUSTRIES LTD	44.1x	51.0%

Recent News

1 positive3 mixed2 general

Ponni Sugars (Erode) Share Price Rise, Valuation and Sector

Univest, 13 OctPrice move

🟡Mixed / dependsA price move, which is not by itself a change in the business. Worth finding the cause before reading it as either good or bad.

Ponni Sugars FY26 Net Profit Rises on Tariff Gain

scanx.trade, 13 OctResults

🟢Potentially positiveReported improvement. Check whether it came from volume, price or a one-off item before treating it as a trend.

ACIF-1 sells entire 5.81% stake in Ponni Sugars (Erode) Ltd

scanx.trade, 14 Oct

Sugar stocks rally up to 11% after govt halves stock limit to 15 days; Bajaj Hindusthan, Ponni Sugars lead

Fortune India, 20 Aug

Ponni Sugars (Erode) Ltd. (PONNIERODE) Share Price Rises 8.43% Today

Univest, 03 AugPrice move

🟡Mixed / dependsA price move, which is not by itself a change in the business. Worth finding the cause before reading it as either good or bad.

Ponni Sugars (Erode) Share Price Up 100% in Less Than 3 Months

Equitypandit, 29 DecPrice move

🟡Mixed / dependsA price move, which is not by itself a change in the business. Worth finding the cause before reading it as either good or bad.

Watch Items

Cross-check against the company's latest quarterly filing / investor presentation before acting.
1 metric couldn't be retrieved for this stock — this is more common for smaller or thinly-covered listings.

DalalBaazaar Thesis

StrongBusiness Quality · Financial Health · Valuation

MiddlingProfitability

WeakGrowth · Risk

Points for each in the Score ↑

Unremarkable in both directions

A reasonable business at a reasonable price. Nothing here is alarming and nothing is compelling, which usually means the decision rests on things this data cannot see — the industry's direction, management's intent, and what else is available to you. 1 high-severity red flag sits above this conclusion and should be read first.

All 4 tripwires holding · see Key things to watch ↑